Mid Atlantic Retina Specialists | Hagerstown, MD

Research site
246 Eastern Boulevard N, Suite 102, Hagerstown, Maryland, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
Diagnostic Test: Fluorescein

This Phase 2 study is conducted to investigate the safety and efficacy of runcaciguat in the treatment of diabetic retinopathy. To assess efficacy, t...

Active, not recruiting
Diabetic Retinopathy
Drug: Runcaciguat (BAY1101042)
Other: Placebo

Trial conditions

Macular Degeneration (4 trials)
Macular Edema (4 trials)
Atrophy (3 trials)
Edema (3 trials)
Geographic Atrophy (3 trials)
Retinal Diseases (3 trials)
Diabetic Retinopathy (2 trials)
Anetoderma (1 trial)
Eye Diseases (1 trial)
Neoplasm Metastasis (1 trial)

And 2 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems